Overview

Topical Curcumin for Precancer Cervical Lesions

Status:
Suspended
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if curcumin can reverse a cervical precancerous state by looking at people who have the condition and intervening with a study drug or placebo (an inactive drug), prior to planned therapeutic loop electrosurgical excision procedure (LEEP) which is a treatment procedure for removing cervical cancer. 40 women with high grade squamous intraepithelial lesion (HSIL) of the cervix will be enrolled to either insert 2000 mg capsule of curcumin or a placebo in their vagina once a week for 12 weeks. After a 4 week long washout period the participants will then undergo removal of the precancerous cells as recommended standard of care. Participants will have regular monthly visits for the duration of the study.
Phase:
Phase 2
Details
Lead Sponsor:
Emory University
Treatments:
Curcumin